Clinical Trials Logo

Alcohol Use Disorder clinical trials

View clinical trials related to Alcohol Use Disorder.

Filter by:

NCT ID: NCT03954054 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Therapeutic Education for Harm Reduction in Patients With Alcohol Use Disorder

ETHER
Start date: May 13, 2019
Phase:
Study type: Observational

Alcohol is the most harmful psychoactive substance in terms of overall damage. Though abstinence remains the objective of most pharmacological and non-pharmacological approaches addressing alcohol use disorder, new therapeutic objectives of reduced alcohol intake and controlled-drinking have emerged. A standardized 10 weeks long, the "ChoiziTaConso" (CTC) therapeutic education program consisting in weekly workshops is one such non-pharmacological intervention that targets the recovery of conscious protective mechanisms with respect to alcohol use. The objective of our study is to measure the effectiveness of this non-pharmacological intervention in reducing alcohol-related harms. The evaluation of the CTC intervention will rely on a sequential explanatory design, where the qualitative study (25 semi-structured interviews) will assist in explaining and interpreting the findings of the controlled before-and-after quantitative study. The evolution of selected outcomes will be compared after 6 months between the treatment group (individuals entering CTC) and the control group (individuals with alcohol use disorder followed-up in standard addiction healthcare facilities).

NCT ID: NCT03952429 Not yet recruiting - Alcohol Dependence Clinical Trials

A Smartphone Based Intervention for the Prevention of Relapse in Alcohol Dependence

SPIRA
Start date: May 16, 2019
Phase: N/A
Study type: Interventional

The rate of relapse following an inpatient alcohol rehabilitation program has been around 50% for a number of years. Offered treatments mainly focus on conscious and controllable aspects of behaviour, but research has found that much of the craving in addiction is guided by automatic processes, which are for a large part unconscious and poorly controlled by the individual. One way to influence these automatic processes is by applying cognitive bias modification, a cognitive-behavioural intervention that can be applied by a computer application. In alcohol addition, a common cognitive bias is the Alcohol-Approach bias. The Anti-Alcohol Training is a form of cognitive bias modification that was developed to reduce this approach bias and it has been shown to reduce the rates of relapse by 4-8%. A drawback of the training is that patients do not continue this at home after discharge. One way to increase accessibility is to offer the training in an app-game form. In this study the investigators have developed a smartphone based training app that allows patients to more easily use the Anti-Alcohol training at home after discharge. The study aims to assess whether use of the app further reduces the alcohol bias and whether it can reduce yearly relapse rates.

NCT ID: NCT03942770 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2

Start date: May 2019
Phase: N/A
Study type: Interventional

Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. As our feasibility study demonstrates, remote breathalyzer monitoring drastically improves the practicality of delivering an alcohol contingency management intervention. In Experiment 2, we will test whether the addition of remote abstinence incentives to treatment as usual improves outpatient treatment outcomes and prevents relapse following inpatient detoxification at a regional hospital system. We will also assess whether readmission rates are reduced using a newly developed smartphone app and breathalyzer.

NCT ID: NCT03932149 Not yet recruiting - Clinical trials for Alcohol Use Disorder

The Effect of Continuous Theta Burst Stimulation (cTBS) in Patients With Alcohol Use Disorder

Start date: May 2019
Phase: N/A
Study type: Interventional

The main purpose of this study is to investigate the efficacy of right DLPFC cTBS in a population of alcohol use disorder patients.

NCT ID: NCT03919695 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda

Start date: September 2019
Phase: N/A
Study type: Interventional

Fisherfolk are a high risk population for HIV and are prioritized to receive antiretroviral treatment (ART) in Uganda, but risky alcohol use among fisherfolk is a barrier to HIV care engagement; multilevel factors influence alcohol use and poor access to HIV care in fishing villages, including a lack of motivation, social support, access to savings accounts, and access to HIV clinics. This project aims to address these barriers, and subsequently reduce heavy alcohol use and increase engagement in HIV care, through an intervention in which counselors provide individual and group counseling to increase motivation, while also addressing structural barriers to care through increased opportunities for savings and increased social support. This may be a feasible approach to help this hard-to-reach population reduce drinking and increase access care, which could ultimately reduce mortality rates, improve treatment outcomes, and through its effect on HIV viral load, decrease the likelihood of transmitting HIV to others.

NCT ID: NCT03904849 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Cannabidiol for Alcohol Use Disorder

Start date: July 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether cannabidiol, relative to placebo, affects subjective response to alcohol or alcohol drinking.

NCT ID: NCT03904498 Not yet recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

COMT Inhibition Among Individuals With Comorbid AUD/ADHD

Start date: July 1, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether the catechol-O-methyltransferase (COMT) inhibitor tolcapone, relative to placebo, affects response to alcohol, decision-making, brain activation associated with alcohol cue reactivity, response inhibition, and selective attention, or alcohol drinking.

NCT ID: NCT03902366 Recruiting - Hepatitis C Clinical Trials

HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function

Start date: May 16, 2019
Phase:
Study type: Observational

The primary objective of this research project is to compare neuropsychiatric functioning, cortical activity, white matter integrity, and immune response among Veterans with and without alcohol use disorder (AUD), before and after direct-acting antiviral (DAA) therapy [a new treatment for chronic infection with the hepatitis C virus (HCV)]. Demographically-matched comparison groups of Veterans without HCV (HCV-, with and without AUD) will similarly be evaluated to determine the relative contribution of HCV and an HCV "cure" to outcomes putatively affected by alcohol abuse. Two specific aims are proposed. Aim 1: Determine the impact of DAA therapy and a sustained viral response on central nervous system (CNS) function. Aim 2: Evaluate the effects of AUD and unhealthy alcohol drinking on DAA therapy outcomes and CNS function. The information learned will address a critical gap in knowledge concerning the effects of alcohol use on DAA therapy outcomes and will help inform treatment guidelines that could be translated to clinical practice, such as targeted interventions to treat AUD in conjunction with HCV infection and follow-up strategies for patients who successfully complete DAA therapy but then need care for other potential CNS-related outcomes.

NCT ID: NCT03902171 Enrolling by invitation - Clinical trials for Alcohol Use Disorder

Soberlink Within In-Home Addiction Treatment Program

Start date: April 2, 2019
Phase:
Study type: Observational

The purpose of this study is to evaluate the impact of use of Soberlink on treatment experience for individuals with alcohol use disorder while enrolled in an In-Home Addiction Treatment program. Treatment engagement, feelings related to autonomy and empowerment, and overall quality of life will be evaluated. Although not the primary focus, recidivism and relapse will be measured.

NCT ID: NCT03898323 Recruiting - Clinical trials for Alcohol Use Disorder

Pilot Human Laboratory Study of Alcohol Approach Bias Modification (AABM) for AUD

ADP + AABM
Start date: February 1, 2019
Phase: N/A
Study type: Interventional

The overall goal of the proposed project is to improve the treatment of individuals with Alcohol Use Disorder (AUD). We will conduct a pilot feasibility trial of Approach Bias Modification (AABM) training of heavy-drinking non-treatment seeking individuals with AUD. We will measure feasibility with respect to recruitment, retention and tolerability of AABM training and the Alcohol Drinking Paradigm (ADP). We will also assess changes in alcohol craving and alcohol consumption during ADP sessions conducted before and after 3 weeks of AABM or sham training.